BackKaruna Therapeutics Overview

Karuna Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for KRTX.

Quarterly EBIT

-$129.59M
↓ 52.39% YoY

As of Dec 31, 2023

Annual EBIT (TTM)

-$496.03M
↓ 71.24% YoY

Trailing 12 months ending Dec 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin